Medicines Australia (MA) has
welcomed the publication of the
report from the Senate Inquiry into
cancer drug availability, saying while
they are a key driver of increases in
patient survival, “the waiting time
to list cancer medicines on the PBS
is taking too long.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 21 Sep 15
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Sep 15
